ClinicalTrials.Veeva

Menu

The Interval Between the Time of Second PEG Dose and the Start of the Colonoscopy (TOSP)

I

Inje University

Status

Completed

Conditions

The Timing of Bowel Preparation in Outpatient Colonoscopy

Treatments

Drug: bowel preparation using split dose of polyethylene glycol

Study type

Observational

Funder types

Other

Identifiers

NCT01286961
HGI 2011-02

Details and patient eligibility

About

As the duration of the interval between the time of last preparation-agent dose and the start of the colonoscopy is increasing, the quality of bowel preparation will be worse.

Full description

The aim of the present studies is to determine how the duration of the interval of the time of last preparation dose and the start of colonoscopy affects the quality of the bowel preparation and when the proper timing of the colonoscopy is after completion of last preparation regimen

Enrollment

360 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult outpatients(18-85 years of age) who undergo colonoscopy for screening, cancer surveillance or with gastrointestinal symptoms, other symptoms

Exclusion criteria

  • age under 18 years, pregnancy, breast feeding, prior history of surgical large bowel resection, severe renal failure (creatinine ≥ 3.0mg/dL (normal 0.8-1.4)), drug addiction or major psychiatric illness; allergy to PEG, refusal of consent to participate in the study.

Trial design

360 participants in 1 patient group

outpatient colonoscopy, bowel preparation, split dose PEG
Description:
adult outpatients who undergo colonoscopy
Treatment:
Drug: bowel preparation using split dose of polyethylene glycol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems